StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
KMBKIMBERLY CLARK CORP
stockpulse.co.kr
Nasdaq
$110.06▼ 0.11%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $36.53BShares out 3.300M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

10
  • 5d agoPre-market26.10.20 19:04
    8-KKey event#●●●#●●●

    KIMBERLY CLARK CORP

    Kimberly-Clark announced the pricing of a $4.9 billion private offering of senior unsecured notes to fund its proposed acquisition of Kenvue. The notes are issued in five tranches with maturities ranging from 2028 to 2036, and the offering is expected to close around October 29, 2026. If the acquisition is not consummated, the company is required to redeem all outstanding notes at 101% of their aggregate principal amount.…more

    $110.06-0.11%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 10.15Pre-market26.10.15 20:08
    8-KKey event

    KIMBERLY CLARK CORP

    Kimberly-Clark announced its preliminary financial results for the third quarter of 2026, reporting net sales of $4.134 billion and an operating profit of $516 million. The company reaffirmed its previously announced full-year 2026 outlook and will release final results on November 5, 2026.…more

    $110.06-0.11%vs prev close
    View filingShare
  • 10.13Pre-market26.10.13 20:06
    8-KKey event

    KIMBERLY CLARK CORP

    Kimberly-Clark has secured the requisite consents for its exchange offers, which involve swapping outstanding Kenvue notes for new Kimberly-Clark notes and cash in connection with the pending acquisition of Kenvue. The consents allow for the elimination of most restrictive covenants and reporting requirements under the Kenvue indenture, with the exchange offers set to expire on October 27, 2026. The settlement is contingent upon the acquisition, which is expected to close in the fourth quarter of 2026.…more

    $110.06-0.11%vs prev close
    View filingShare

9 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 4d agoRegular26.10.20 23:16
    #●●●#●●●

    China Unconditionally Approves Kimberly-Clark’s Acquisition Of Kenvue

    Chinese regulators have granted unconditional approval for Kimberly-Clark's acquisition of Kenvue, clearing a major antitrust hurdle. This regulatory clearance is expected to accelerate the overall merger process between the two companies.…more

    $110.06-0.11%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 5d agoOvernight26.10.20 14:41

    ●●●●●●●● ●●●●● ●●●●●●

    Kimberly-Clark is issuing $4.9 billion in senior notes across five tranches to fund its acquisition of Kenvue. This significant debt issuance to finance the acquisition may increase the company's financial leverage.…more

    $110.06-0.11%vs prev close
    ShareBenzinga
  • 10.16Regular26.10.16 23:52

    ●●●●●●●● ●●●●● ●●●●●●

    Kimberly-Clark is preparing to issue bonds to finance its upcoming acquisition of the Tylenol manufacturer. Investors should monitor the impact of this significant debt-funded purchase on the company's balance sheet.…more

    $110.06-0.11%vs prev close
    ShareBenzinga

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →